GT-838

N/A

Report date: 2024/11/01 16:14:24
NME

Base Information

Drug NameGT-838
Drug Alias NameGT-838GT838
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLymphoma, Large-Cell, Anaplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGluetacs Therapeutics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGluetacs Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, Large-Cell, Anaplastic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A